US OptionsDetailed Quotes

DAVE241115P65000

Watchlist

0.00
0.000.00%

15min DelayTrading Oct 31 09:30 ET

0.00High0.00Low

Dave Inc Stock Discussion

Tonyco

Oct 17 16:59

$Dave Inc (DAVE.US)$
Buy the dip! My initial position is $34.3 but I added more at $37.83.
If the pullback gains power I want to add alot more next time.

Tonyco

Aug 5 15:24

Instead of panicking...

While the others take big losses selling everything they have, I feel the more rational decision is to do nothing.
The tech sector, specifically semiconductors and Ai/crypto companies, aren't going anywhere. NVDA isn't going to just shrug their shoulders and give up tomorrow.
So long as you have researched and relied on financials, I think it will all come back and probably stronger than ever.
In the meantime, I've added to a couple of "defense" stocks:
$ADMA Biologics (ADMA.US)$ : 58.8% U...

Chip stocks hit hard, intel's earnings disappoint: Still a good bet?

Tonyco

Jul 10 08:06

Today grabbing
$Dave Inc (DAVE.US)$
PT $41+ SL $27
$Desktop Metal (DM.US)$
LT PT: $17+
$Hims & Hers Health (HIMS.US)$
LT PT: $39.27+
$Intel (INTC.US)$
PT: $50 SL: $25
Medium duration, 14-30 days min.

Mars Mooo

May 1 04:18

Ten stocks with >300% YTD, Top 5 Gainers (30 Apr), and Quick Poll on the Fed interest rate decisions on 1 May 2024.

Hello Mooers!
A quick recap for the month ending April 30, 2024.
Ten stocks with >300% YTD
$Swvl Holdings (SWVL.US)$718.40%
$Root Inc (ROOT.US)$564.60%
$Elevation Oncology (ELEV.US)$561.08%
$JanOne (JAN.US)$554.05%
$GeneDx Holdings (WGS.US)$520.71%
$Corbus Pharmaceuticals (CRBP.US)$513.25%
$AGBA Group (AGBA.US)$482.90%
$Janux Therapeutics (JANX.US)$431.22%
$Dave Inc (DAVE.US)$4...

Moomoo AI

Feb 22 05:40

Despite strong revenue growth, Dave's low P/S ratio may indicate investor belief of underperformance in the broader industry. Shareholders may think recent performance has peaked, leading to lower selling prices. The low P/S ratio could signal price risks if medium-term revenue trends persist, but investors anticipate future revenue volatility.

Even With A 53% Surge, Cautious Investors Are Not Rewarding Dave Inc.'s (NASDAQ:DAVE) Performance Completely

Moomoo AI

Jan 30 08:18

Dave Inc.'s CEO, Jason Wilk, sees the recent transaction as a major advancement for the company, offering a unique chance to increase shareholder value. He remains confident in the company's ability to meet its growth and profitability goals in the future quarters.

Press Release: Dave's Repurchase of FTX Convertible Note for $71 Million Finalized

Dreamhouse22

Jan 2 16:39

$Dave Inc (DAVE.US)$ Something not right… it is now at 9.05

Moomoo AI

Dec 13, 2023 05:13

Despite strong revenue growth that outpaces the industry, Dave's P/S ratio is surprisingly low. This could suggest underlying risks to the company's future performance as investors may not be convinced the company can maintain its recent growth rates.

A Piece Of The Puzzle Missing From Dave Inc.'s (NASDAQ:DAVE) 44% Share Price Climb

Alvinnnnnnngenius

Jul 10, 2023 17:37

Insider load watch closely

$Dave Inc (DAVE.US)$
$Nabriva Therapeutics (NBRV.US)$

Dreamhouse22

Mar 6, 2023 16:15

Clowns

$Dave Inc (DAVE.US)$ what a bunch of clowns. Stellar revenue. and it will get better and better

No comment yet